The NOD2 agonist muramyl-di-peptide (MDP) reverses the inhibitory effects of TLR4 activation on enterocyte proliferation through effects on beta-catenin signaling, and attenuates the severity of experimental necrotizing enterocolitis
Richardson, Ward M., MD, Shi, Xiao-Hua, PhD, Gribar, Steven C., MD, Branca, Maria, BA, Dubowski, Theresa, BA, Li, Jun, Sodhi, Chhindler, PhD, Hackam, David J., MD, PhD, FACS
Published in Journal of the American College of Surgeons (2008)
Published in Journal of the American College of Surgeons (2008)
Get full text
Journal Article